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Summary
We have characterized the mast cell stimulating activity of murine cytokine synthesis inhibitory
factor, referred to as interleukin 10 (IWO) . It was found that IL10 alone failed to support the
growth of mast cell lines and mast cell progenitors. Nevertheless, it dramatically enhanced their
growth when combined withIL3 or IL4 . Moreover, IL4 plus IL10 supported the proliferation
of mast cells as well as IL-3, suggesting that these two factors may provide a pathway for their
development independent of IL3 . However, optimal mast cell growth was stimulated by the
combination of 11,10, 114, and IL3 . This particular set of cytokines are coordinately produced
by activated T cells and may constitute an effective network regulating early and late stages of
mast cell development during certain immune responses.
E
arly studies with mutant strains of mice suggested that
T cell factors are necessary for the growth of mucosal
mast cells (1) . Several of these factors have been molecularly
defined and characterized in various bioassays . Of these, only
11,3 has been shown to support the growth of both long-
term mast cell lines and freshly isolated mast cell progenitors
(2) . In contrast, 11,4 is only weakly stimulatory for most
cell lines (3) and is unable to stimulate progenitor cells (4) .
Nevertheless, 11,4 potentiates their IL3-dependent growth,
suggesting that it functions primarily as a cofactor. Recently,
IL9/P40/MEA was alsoshown to enhance the IL3-dependent
growth of mast cells, similar to IL4 (5) . These studies indi-
cate that the optimal growth of mast cells is dependent on
multiple factor interactions. Identification of such cytokine
networks may help explain the profound regulatory effects
that T cells exert on this lineage during certain allergic and
inflammatory responses.
In the present study, we have assessed the mast cell stimula-
tory activities of a new T cell-derived factor called IL-10 (8) .
Although this factor was first described as cytokine synthesis
inhibitory factor (CSIF) (6), subsequent studies have revealed
its pleiotropic activities (7, 8) . Apparently, this factor is also
produced by B cells and may account for the novel mast cell
stimulatory activity detected in their supernatants (9) . Herein,
it is shown that 11710 is a potent coregulator of mast cell
growth.
Materials and Methods
Animals.
￿
C57BL/6 mice and Wistar rats were purchased from
Simonsen Laboratory (Gilroy, CA) .
Cytokinesand Antibodies.
￿
Purified murine rIL3 (sp act = 1.5
x 108 U/mg) was a gift ofDr. J . Schreurs (DNAX). Purified mu-
rine rI1,4 (sp act = 6 x 107 U/mg) was generously provided by
Schering-Plough Research (Bloomfield, NJ) . One standard unit of
activity is defined as the amount of factor necessary to produce
a half-maximal response by theMC/9 mast cell line. Purified rIL10
(sp act = 2 x 10' U/mg) was a gift of B. Castle andW Dang
(DNAX) . Anti-CD4 (GK1.5) and antiThy-1 (30H12) mAbs were
gifts ofDr. M . Kehry (DNAX) .
MC/9 Mast Cell Line.
￿
The murine mast cell line, MC/9, was
maintained inRPMI 1640 (Gibco Laboratories, Grand Island, NY)
supplemented with 10% FCS, 50mM 2-ME, and5% supernatant
from Con A-activated T cells .
Infection with Nippostronglylus brasiliensis (Nb).
￿
Nb larvae were
maintained by passage through rats as described (10). Mice were
infected subcutaneously with 1,000 stage 3 larvae (L3), and 14 d
later were killed by C02 asphyxiation .
ClonalMast CellAssay.
￿
Mesenteric lymph nodes from C57BL/6
mice infected with 1,000 L3 ofNb were depleted ofT cells after
treatment with anti-CD4 (GK1.5) and anti-Thy-1 (30Hi2) anti-
bodies and goat anti-raf IgG-coated magnetic beads (Advanced
Magnetics Inc., Cambridge, MA) . The unbound cells usually rep-
resented 10-20% ofall mesenteric lymph node cells(MLNC) and
contained <5% T cells . The T cell-depletedMLNC were cultured
at 4 x 10 5 cells/ml in modified Iscove's medium (Gibco labora-
tories) supplemented with 20% FCS, 0.8% (wt/vol) methylcellu-
lose, 50mM 2-ME, and saturating concentrations ofvarious growth
factors . After 14 d in culture, the size and number ofcolonies were
scored .
Staining ofCultured Cells.
￿
Individual colonies from methylcel-
lulose cultures were transferred onto glass slides and stained with
Wright's-Giemsa for morphological analysis . To identify the pres-
ence ofconnective tissue mast cells (CTMC), colonies were picked
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tute, Rowley, MA) or with berberine sulfate (Sigma ChemicalCo.,
St . Louis, MO) to determine heparin-containing granules . Mature
CTMC have been shown to stain alcian blue+/- , safranin', and
berberine sulfate' .
Electron Microscopy.
￿
Mast cell colonies were prepared and ex-
amined by electron microscopy byDr. R. Sibley, and P. Huie (Stan-
ford University, Stanford, CA) .
Proliferation Assay.
￿
5 x 103 MC/9 mast cells were plated in
flat-bottomed 24-well plates (Falcon Labware, Oxnard, CA) con-
taining 1 ml ofRPMI 1640,10% FCS, 50mM 2-ME, and varying
concentrations ofcytokines . After 3 d of culture, cell counts were
performed on triplicate cultures using a cell counter (Coulter Elec-
tronics Inc., Hialeah, FL).
Results and Discussion
IL10 Enhances the 11,3- and IL4-dependent Growth ofa Mast
Cell Line, MC/9. The mast cell stimulatory activity of11,10
was assessed in a 3-d proliferation assay. It was found that
11,10 failed to induce the proliferation ofMC/9 cells, although
it extended their viability for 1-2 d (data not shown) .
Nevertheless, IL-10 (at >10 U/ml) caused a modest enhance-
ment in their growth when combined with an optimal con-
centration of IL3 (Fig . 1) . In separate experiments, we ob-
served that 11,10 enhancement was more pronounced when
sub-optimal amounts of IL3 were used (data not shown) .
IL-10 was also found to increase the growth of MC/9 cells
in response to 11,4 (Fig . 1) . In this case, marked synergy was
observed at sub-optimal as well as saturating concentrations
of IL4 . Because 11,4 is less stimulatory for various mast cell
Figure 1 .
￿
11,10 enhances the factor-dependent growth of MC/9 mast
cells. MC/9 mast cells (at 5 x 103 cells/ml) were cultured for 3 d with
11,3 (200 U/ml), 11,4 (200 U/ml), 1140 (25 U/ml) or combinations of
these factors as indicated . Cell numberswere determined using a cell counter
(Coulter Electronics Inc.) . Data are reported as mean ± SD of triplicate
cultures.
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lines than 11,3 (3), it was of great interest that the combina-
tion of IL10 and IL4 was almost as effective as IL3 (Fig .
1) . These results suggest that 11,10 and IL4 are able to sup-
port the growth of mast cells in the absence of IL3 . This
may be important in certain in vivo conditions where IL3
is either absent or extremely limited. It has already been
demonstrated that the combined actions of 11,4 and I1r3 are
much more effective in stimulating mast cell growth than
each factor alone (3) . Here, we show that 11710 further aug-
ments the stimulatory effects of saturating levels of 11,4 +
IL3 (Fig . 1) .
IL10 Is a Potent Cofactorfor Colony Formation by Mast Cell
Progenitors. To assess whether IL10 could affect the growth
of mast cell progenitors, clonal assays in semi-solid medium
were performed with T cell-depleted MLNC isolated from
Nb-infected mice. MLNC from parasitized mice are an en-
riched source of mast cell progenitors and do not contain
significant numbers of other lymphoid precursors (personal
observation) . Our results show that progenitor cells were com-
pletely unresponsive to 11,10 and responded poorly even to
high concentrations of IL3 or 11,4 (Fig. 2) . However, the
combination of any two ofthese factors resulted in a marked
increase in mast cell colony formation. For example, when
11,10 was combined with IL3 or IL4, colony numbers were
increased 13- or 15-fold, respectively (Fig . 2) . The most pro-
found growth was elicited by a combination of all three factors,
Figure 2 .
￿
11,10 is cofactor for
mast cell progenitor growth . T
cell-depleted MLNC from Nb-
infected mice were cultured with
11,3 (200 U/ml), IL4 (300 U/ml),
IIA0 (300 U/ml), or combina-
tions thereof. Colonies (con-
taining >50 cells) were enumer-
ated on day 14 ofculture, Data are
reported as mean ± SD of tripli-
cate cultures .
Figure 3 .
￿
11,10 augments colony size. Shown are typical colonies found
in cultures stimulated with 11,3 + IL4 in the absence (A) and presence
(B) of IIA0 (x150).suggesting that some mast cell progenitors require multiple
factor interactions in order to initiate clonal growth . Moreover,
the combination of 11,3 + 114 + 11,10 not only increased
thenumber ofcolonies, but it also dramatically increased their
size. This is illustrated in Fig. 3, where the average diameter
and density of colonies supported by 110 + IIr4 + IL10
is shown to be greater than those supported by IL3 + IL4 .
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This result indicates that the continuous proliferation of
daughter cells within individual colonies was enhanced by
the presence of 1140 . This outcome is analogous to results
of studies showing that optimal growth ofother hematopoi-
etic lineages is also dependent on interactions with more than
one factor (11) .
Next, individual colonies from each experimental group
Figure 4.
￿
IL10 augments production
of pure mast cell colonies. Cells from
individual colonies were analyzed for
morphology by light and electron mi-
croscopy. Greater than 98% of all the
colonies generated in cultures supple-
mented with 11,3 + IL4 + IL10 con-
sisted of pure mast cells identified by
the presenceofmetachromatic granules
after staining with Wright's-Giemsa (A)
(x2,000) . An electron micrograph of
a typical cell (B) confirms its immature
state by the presence of cytoplasmic
vacuoles incompletely filled with dense
material (small arrows) and only an oc-
casional dense granule (large arrow)
(x 8,500) . N - nucleus .were analyzed for cellular composition and were found to
consist entirely of mast cells (Fig . 4 A) . To determine whether
CTMC were present, cells were stained with berberine sul-
fate to detect heparin . All colonies tested were negative. Fur-
thermore, none of the cells stained with safranin, while all
stained with alcian blue (data not shown) . Thus, it appears
that the colonies generated by various concentrations of 1173,
IIr4, and RAO were composed of mucosal-like mast cells.
This was confirmed by the ultrastructural appearance of cy-
toplasmic vacuoles containing small electron-dense progranules
(Fig . 4 B) similar to those previously described for several
immature mucosal mast cell lines (1) .
Because ILA0 has been shown to be a product of activated
T cell (6) and B cell subsets (9), it is likely to play a role
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